Respire_final-01
  • CORPORATE
    • Company Overview
    • Board of Directors
    • RespireRx Organization Structure
    • Social Media Guidelines
    • Conflicts of Interest Policy
  • NEUROTRANSMISSION
  • RESOLUTIONRX
    • Cannabinoid Platform Summary
    • Pharmaceutical Cannabinoids
    • Obstructive Sleep Apnea
    • Dronabinol for the Treatment of Obstructive Sleep Apnea
    • Regulatory Process
  • ENDEAVOURRX
    • Neuromodulators
    • Ampakines
      • AMPAkine Platform Summary
      • Lead Compounds
      • Attention Deficit Hyperactivity Disorder (ADHD)
      • Spinal Cord Injury (SCI)
    • GABAkines
      • GABAkines Platform Summary
      • Background
      • Epilepsy
      • Pain
  • PRODUCT PIPELINE
  • INVESTORS
    • Investor Contact
    • SEC Reports
    • News
    • FAQs
    • Presentations
  • CONTACT

Author: j3ff1

Home Articles Posted by j3ff1 (Page 9)
131 posts, 0 comments

RespireRx Presentation at 2017 Rodman & Renshaw Conference on 09/12/17

September 8, 2017j3ff1
Read More

RespireRx Pharmaceuticals Inc. to Present at 2017 Rodman & Renshaw Conference

September 8, 2017j3ff1
Read More

RespireRx Pharmaceuticals Inc. Files June 30, 2017 Quarterly Report on Form 10-Q And Provides Update

August 25, 2017j3ff1
Read More

July 11, 2017j3ff1
Read More

Ampakines Executive Summary

July 11, 2017j3ff1
Read More

Dronabinol Executive Summary

July 11, 2017j3ff1
Read More

Ampakines Platform

July 11, 2017j3ff1
Read More

Cannabinoid Platform

July 11, 2017j3ff1
Read More

06/16/17 – RespireRx presentation at 2017 Marcum MicroCap Conference

June 16, 2017j3ff1
Read More

RespireRx Pharmaceuticals Inc. to Present at the 2017 Marcum MicroCap Conference

June 14, 2017j3ff1
Read More

Posts pagination

< 1 … 6 7 8 9 10 11 12 … 14 >

RespireRx Organization Structure

  • RespireRx Organization Structure
  • Arnold S. Lippa, PhD
    • Richard Purcell
    • David Dickason
    • James Cook
    • Jeffrey M. Witkin
    • Rok Cerne
  • Jeff Margolis
©2016 RespireRx Phamaceuticals Inc. All Rights Reserved.